CDSCO granted restricted EUA to vaccinate children
April 26, 2022
Central Drugs Standard Control Organization (CDSCO), the Drug Regulatory Agency of Government of India granted restricted emergency use authorization (EUA) to Bharat Biotech’s Covaxin as a COVID-19 vaccine to vaccinate children between the age of 6-12 years. Besides, the drug regulator also granted emergency use authorization to Corbevax (Biological E vaccine) for children between the age of 5-12 years and ZycovD (Zydus Cadila vaccine) for children above the age of 12 years. The information has also been tweeted by Health Minister Dr Mansukh Mandaviya.